INTRODUCTION
Definition
A clinical condition due to airway hyper-responsiveness, characterised by airway inflammation and manifesting clinically as wheezing, cough, difficulty in breathing, and chest tightness
It may resolve spontaneously or following treatment.
Introduction
It is a common chronic disease
- 2nd commonest after Pulmonary Tuberculosis
The prevalence is increasing due to urbanisation
Asthma is a syndrome characterised by;
airway inflammation and remodelling
airway hyper-responsiveness
variable but reversible airway/airflow obstruction.
Asthma is a heterogeneous condition where genetic and environmental factors may interact.
There is strong evidence that childhood asthma consists of a range of separate disorders.
Asthma characteristically affects the small and medium-sized bronchi usually 2 to 5mm in diameter.
The airflow limitation results from bronchial spasm, mucosal oedema, excessive tenacious secretions.
Majority of subjects are genetically predisposed.
Environmental pollutants and other trigger factors play a major role in asthma exacerbation.
Asthma manifests with a variety of symptoms, none of which is specific to asthma.
Two main age groups are discernable in childhood asthma
- younger children (younger than 12 years) d
adolescent (aged 12 years and above)
Epidemiology
One of the most common chronic diseases of childhood
Prevalence is increasing worldwide
More common in:
Children with family history of atopy
Urban populations
Male predominance in early childhood; female predominance in adolescence
Etiology and Risk Factors
Pathophysiology
Pathogenesis
Trigger factors
Asthma phenotypes
The outward, external and physical manifestation of a disease condition (asthma)
A cluster of clinical or pathologic features that are associated with the disease
Useful in managing the patient or understanding the mechanism of the disease
Aspirin and other non-steroidal anti-inflammatory drugs
Environmental allergens
Occupational allergens or irritants
Exercise
Basically
1. Transient wheezing (<1yr)
2. Non-atopic wheezing in toddlers (1-3 yrs)
3. Ig E mediated wheeze/asthma (4-12 yrs)
4. Late onset childhood asthma (> 12 yrs)
Asthma phenotypes chat gpt
Asthma phenotypes refer to clinically recognizable patterns of asthma based on age of onset, triggers, clinical course, inflammatory profile, and response to therapy.
b. Persistent Wheezers
Onset: Early childhood
Symptoms continue beyond 5 years
Often associated with atopy
Reduced lung function
Progresses to chronic asthma
c. Late-Onset Wheezers
Onset: After 3 years
Often allergic
Symptoms persist into adolescence
Clinical features
Asthma is a dual-component disease
Symptoms and signs depend on the severity of the disease.
Common symptoms
- wheeze,
shortness of breath
chest tightness cough
The hallmark of asthma is that these symptoms tend to be:
variable
intermittent
worse at night
provoked by triggers including exercise.
Signs
Wheeze (bilateral, diffuse, expiratory, polyphonic)
Reduced lung function
Clinical features
Precipitated by:
Viral infections, Exercise, Cold air, Exposure to allergens
b. Cough
Common presenting symptom in children
Usually:
Dry or minimally productive,
Worse at night or early morning,
May be the only symptom (cough-variant asthma)
c. Breathlessness (Dyspnea)
Episodic
Occurs during acute exacerbations
May limit play or physical activity in children
d. Chest Tightness
Older children and adolescents may complain
Often accompanies wheeze and dyspnea
CONDITIONS THAT LOOK LIKE ASTHMA..
Reflux oesophagitis, TOF etc.
Bronchiolitis, pneumonia, sinusitis etc.
Pulmonary tuberculosis, laryngeal papillomatosis etc.
Cardiac failure and dilated cardiomyopathies
Inhaled foreign bodies
Tracheomalacia and bronchomalacia
Vocal cord dysfunction
Diagnosis
eosinophils, Ig E levels (total and specific)
Lung Function Test
FEV/FVC 25-759 - Spirometry: FEV₁, FVC, FEV,
Objective assessment
FEV1/FVC ratio less than 75%; or PEFR less than 80% of predicted or best
PEFR increase more than 15%; 15-20 mins after inhalation of a rapid-acting ẞ,- agonist
PEFR decrease more than 15% 15-20 mins after inhalation of cholinergic drug
PEFR fall more than 15% after a 6-minute of sustained running or other exercises
PEFR varies more than 20% from morning measurement upon rising to measurement 12 hrs later in patients taking bronchodilators (more than 10% in patients who are not on bronchodilators)
Classification (severity)
Classification of asthma